Results 171 to 180 of about 35,270 (248)

Population pharmacokinetics and optimized dosing of piperacillin-tazobactam in hematological patients with febrile neutropenia. [PDF]

Antimicrob Agents Chemother
Laporte-Amargos J, Ulldemolins M, Hernández-Mitre MP, Roberts JA, Rigo-Bonnin R, Carmona-Torre F, Huguet M, Puerta-Alcalde P, Arnan M, Del Pozo JL, Torrent A, García-Vidal C, Sureda A, Bergas A, Sastre-Escolà E, Carratalà J, Gudiol C.   +16 more
europepmc   +1 more source

A Computational Approach to Evaluating Empirical Antibiotic Coverage for Gram-Negative Bloodstream Infections in Pediatric Febrile Neutropenia. [PDF]

Antibiotics (Basel)
Cappozzo F, Mariani M, Caci E, Bandettini R, Mesini A, Ricci E, Saffioti C, Dufour C, Faraci M, Garaventa A, Milanaccio C, Bagnasco F, Toto M, Castagnola E.   +13 more
europepmc   +1 more source

Early Discontinuation of Empiric Antibiotic Therapy in Children with Cancer and Febrile Neutropenia: A Narrative Review. [PDF]

Medicina (Kaunas)
Papachristidou S, Dimopoulou D, Pantalos G, Doganis D, Pasparaki S, Kossiva L, Papaevangelou V, Tsolia M.   +7 more
europepmc   +1 more source

The value of plasma presepsin as a diagnostic and prognostic biomarker for febrile neutropenia in children. [PDF]

Ann Med
Liang J, Luo J, Li G, Li L, Wu J.
europepmc   +1 more source

Effect of Fresh versus Cryopreserved Grafts on Febrile Neutropenia and Infections in Allogeneic Hematopoietic Cell Transplantation: Factors Determining Mortality. [PDF]

Mediterr J Hematol Infect Dis
Yalçın C, Orhan B, Ersal T, Şentürk M, Özkocaman V, Akalın H, Özkalemkaş F.   +6 more
europepmc   +1 more source

Sacituzumab-induced severe or febrile neutropenia and G-CSF utilization and cost for advanced HER2-negative breast cancer: a single-center retrospective analysis. [PDF]

Breast Cancer Res Treat
Tam G, Waddell D, Freeman JQ, Chen N, Yang H.   +4 more
europepmc   +1 more source

Febrile Neutropenia in the Context of Clozapine-Induced Agranulocytosis (CIA) and Myelodysplastic Syndrome: Importance of a Multidisciplinary Approach. [PDF]

Cureus
Conchinha AF, Pack T, Rodrigues A, Lopes A, Santos A.   +4 more
europepmc   +1 more source

Fosfomycin versus ciprofloxacin for febrile neutropenia prophylaxis in high-risk haematological patients (FOVOCIP): a phase 3, open-label, multicentre, randomised, non-inferiority trial. [PDF]

Lancet Reg Health Eur
Moreno AF, López de Ugarriza P, González Huerta AJ, Pascual BB, Cáceres S, Blanco LS, Calabuig ML, Zarzuela MP, Rodríguez-Veiga R, Montesinos P, Fernández Verdugo AM, González-Barbera EM, Izquierdo M, Medel-Plaza M, Colomina J, Olave MT, Humala K, López L, Labrador J, Seral C, Amigo ML, de Toro M, Carrascoso GR, Megías G, Blázquez R, Antuña M, Lumbreras P, Domínguez JF, Bernal T.   +28 more
europepmc   +1 more source

Evaluation of a Febrile Neutropenia Protocol Implemented at Triage in an Emergency Department. [PDF]

Medicines (Basel)
Stramel-Stafford S, Townsend H, Trimmer B, Cohen J, Thompson J.   +4 more
europepmc   +1 more source

Evaluation of Direct Medical Costs Associated With High-Risk Febrile Neutropenia Among Cancer Patients in a Tertiary Care Center. [PDF]

Cureus
Bvsn S, Ravichandran M, Kayal S, S K.
europepmc   +1 more source